Literature DB >> 22652797

Association between obesity and gallbladder cancer.

Fei Wang1, Bingyuan Wang, Liang Qiao.   

Abstract

Obesity has become a global health issue because of its increased morbidity and mortality, and a close association with at least 20 different cancers. Clinical and epidemiological studies have suggested that obesity and overweight are positively related with the risk of GBC. Gallbladder cancer (GBC) is a relatively infrequent but highly lethal neoplasm. Obesity may disturb lipid and endogenous hormones metabolism, affect gallbladder motility, increase the risk of gallstones, and thus plays a role in GBC. Control of obesity through measures such as lifestyle modification, healthy diet, and regular exercise may prove useful in the prevention of GBC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22652797     DOI: 10.2741/4070

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  8 in total

1.  CYP17 polymorphism (rs743572) is associated with increased risk of gallbladder cancer in tobacco users.

Authors:  Rajani Rai; Kiran L Sharma; Sanjeev Misra; Ashok Kumar; Balraj Mittal
Journal:  Tumour Biol       Date:  2014-04-01

Review 2.  Obesity and Cancer: An Angiogenic and Inflammatory Link.

Authors:  Dai Fukumura; Joao Incio; Ram C Shankaraiah; Rakesh K Jain
Journal:  Microcirculation       Date:  2016-04       Impact factor: 2.628

Review 3.  Tea consumption and the risk of biliary tract cancer: a systematic review and dose-response meta-analysis of observational studies.

Authors:  Jianping Xiong; Jianzhen Lin; Anqiang Wang; Yaqin Wang; Ying Zheng; Xinting Sang; Yiyao Xu; Xin Lu; Haitao Zhao
Journal:  Oncotarget       Date:  2017-06-13

Review 4.  Obesity-Related Digestive Diseases and Their Pathophysiology.

Authors:  Su Youn Nam
Journal:  Gut Liver       Date:  2017-05-15       Impact factor: 4.519

5.  α-Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades.

Authors:  Yu Shi; Yangwei Fan; Yuan Hu; Jiayu Jing; Chuying Wang; Yinying Wu; Qianqian Geng; Xuyuan Dong; Enxiao Li; Danfeng Dong
Journal:  J Cell Mol Med       Date:  2019-11-25       Impact factor: 5.310

Review 6.  The role of diet and nutrition related indicators in biliary diseases: an umbrella review of systematic review and meta-analysis.

Authors:  Yaoqun Wang; Jiong Lu; Ningyuan Wen; Guilin Nie; Dingzhong Peng; Xianze Xiong; Nansheng Cheng; Bei Li
Journal:  Nutr Metab (Lond)       Date:  2022-07-30       Impact factor: 4.654

7.  HDAC1 promoted migration and invasion binding with TCF12 by promoting EMT progress in gallbladder cancer.

Authors:  Junyi He; Sheng Shen; Weiqi Lu; Yuhong Zhou; Yingyong Hou; Yong Zhang; Ying Jiang; Houbao Liu; Yebo Shao
Journal:  Oncotarget       Date:  2016-05-31

8.  Tamoxifen inhibits cell proliferation by impaired glucose metabolism in gallbladder cancer.

Authors:  Shuai Huang; Hui Wang; Wei Chen; Ming Zhan; Sunwang Xu; Xince Huang; Ruirong Lin; Hui Shen; Jian Wang
Journal:  J Cell Mol Med       Date:  2019-11-28       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.